Whereas TRAIL-R1 was downregulated in HCC in comparison to normal liver tissue, TRAIL-R2 and –R4 were upregulated in HCC, especially in G2 and G3 tumors. The gene discussed is TNFRSF10A; the disease is hepatocellular carcinoma.